Cargando…
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422532/ https://www.ncbi.nlm.nih.gov/pubmed/28496341 http://dx.doi.org/10.2147/OTT.S140498 |
Ejemplares similares
-
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
por: Li, Xuelu, et al.
Publicado: (2017) -
Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
por: Alam, S M, et al.
Publicado: (2008) -
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
por: Randolph, Matthew E., et al.
Publicado: (2017) -
EphrinB2–EphB4 Signaling in Neurooncological Disease
por: Piffko, Andras, et al.
Publicado: (2022) -
EphB/ephrinB Signaling in Cell Adhesion and Migration
por: Park, Inji, et al.
Publicado: (2015)